FA
Evaluate biomarkers in primary tumor that could predict response to PARPi such as BRCA-1/2, FANCD2 nuclear foci formation (using the FA Triple Stain Immunofluroscence test/FATSI) and expression of miR 155 (oncogenic miR that targets DNA repair genes).